Drugmaker Eli Lilly has announced a $35 cap on the monthly cost of insulin, in response to public and presidential pressure over the cots of the diabetes medication.
It mirrors a law passed last year that capped costs at $35 per month for people with government health insurance.
President Biden has praised the move.
Kate Fisher reports for Washington
IN: Eli Lilly
OUT: SOC
DUR: 40
LINK: